Annual report pursuant to Section 13 and 15(d)

6. LICENSE AGREEMENT OBLIGATION

v3.5.0.2
6. LICENSE AGREEMENT OBLIGATION
12 Months Ended
Apr. 30, 2016
Debt Disclosure [Abstract]  
LICENSE AGREEMENT OBLIGATION

 

The Company entered into a licensing agreement for a license to use the Cell-in-a-Box® technology to develop therapies involving Cannabis for a total amount of $2,000,000 “Upfront Payment” for the license (see Note 12). At April 30, 2016 and 2015, the Company’s license agreement obligations were $150,000 and $1,000,000, respectively.